Transcriptional Interactomic Inhibition of ROR[alpha] Suppresses Th17-Related Inflammation
Purpose: Th17 cells and their cytokines are implicated in the pathogenesis of various autoimmune diseases. Retinoic acid-related orphan receptor alpha (ROR[alpha]) is a transcription factor for the differentiation and the inflammatory functions of Th17 cells. In this study, we generated the nucleus-...
Gespeichert in:
| Veröffentlicht in: | Journal of inflammation research 2021-12, Vol.14, p.7091 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | 7091 |
| container_title | Journal of inflammation research |
| container_volume | 14 |
| creator | Ho, Chun-Chang Kim, Giha Mun, Chin Hee Kim, Ju-Won Han, Jieun Park, Ji Yoon Park, Yong-Beom Lee, Sang-Kyou |
| description | Purpose: Th17 cells and their cytokines are implicated in the pathogenesis of various autoimmune diseases. Retinoic acid-related orphan receptor alpha (ROR[alpha]) is a transcription factor for the differentiation and the inflammatory functions of Th17 cells. In this study, we generated the nucleus-transducible form of transcription modulation domain of ROR[alpha] (nt-ROR[alpha]-TMD) to investigate the functional roles of ROR[alpha] in vitro and in vivo under normal physiological condition without genetic alteration. Methods: The functions of nt-ROR[alpha]-TMD were analyzed in vitro through flow cytometry, luciferase assay, ELISA, and transcriptome sequencing. Finally, the in vivo therapeutic effects of nt-ROR[alpha]-TMD were verified in dextran sulfate sodium (DSS)-induced colitis mice. Results: nt-ROR[alpha]-TMD was effectively delivered into the cell nucleus in a dose- and time-dependent manner without any cellular toxicity. nt-ROR[alpha]-TMD competitively inhibited the ROR[alpha]-mediated transcription but not ROR[gamma]t-mediated transcription. Secretion of IL-17A from the splenocytes was suppressed by nt-ROR[alpha]-TMD without affecting the secretion of Th1- or Th2-type cytokine and T cell activation events such as induction of CD69 and CD25. The differentiation potential of naive T cells into Th17 cells, not into Th1, Th2, or Treg cells, was significantly blocked by nt-ROR[alpha]-TMD. Consistently, mRNA sequencing analysis showed that nt-ROR[alpha]-TMD treatment down-regulated the expression of the genes related to the differentiation and functions of Th17 cells. Treatment of DSS-induced colitis mice with nt-ROR[alpha]-TMD improved the overall symptoms of colitis, such as body weight change, colon length, infiltration of inflammatory cells, and the level of inflammatory cytokines in the serum. In the mesenteric lymph node (MLN) of the nt-ROR[alpha]-TMD-treated mice, the population of CD4+IL-17A+ Th17 cells was reduced, and the population of CD4+Foxp3+ Treg cells increased. Conclusion: nt-ROR[alpha]-TMD has a potential to be developed as a novel therapeutic reagent for treating various inflammatory diseases in which Th17 cells are the leading pathological player. Keywords: retinoic acid-related orphan receptor, T helper 17, transcriptional modulation, DSS-induced colitis, inflammatory disease |
| doi_str_mv | 10.2147/JIR.S344031 |
| format | Article |
| fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A689495178</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A689495178</galeid><sourcerecordid>A689495178</sourcerecordid><originalsourceid>FETCH-LOGICAL-g988-6a533368c19e0b098b0cd44c6c1b9993ca1326ffb18c251c016260f66137913b3</originalsourceid><addsrcrecordid>eNptT01rwzAMNWODla6n_YHAYLd0Vuw69rGUbc0oFNKcNkZxHLvxcD6I0_8_h-3QwaSDnqT3hB5C94CXCdD06S3LlwdCKSZwhWYAKY_TgK8v8C1aeP-Fp0gxTegMvReDbL0abD_arpUuytpRD1KNXWNVaGpb2mkTdSbK9_mHdH0tP6PDue8H7b32UVFDGufayVFXQWCcbBo5Se7QjZHO68VvnaPi5bnYbOPd_jXbrHfxSXAeM7kihDCuQGhcYsFLrCpKFVNQCiGIkkASZkwJXCUrUBhYwrBhDEgqgJRkjh5-zp6k00fbmm4M_zfWq-OacUHFKrgPrOU_rJCVDka7Vhsb5n8EjxeCWks31r5z58mZvyR-Axmnb-U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Transcriptional Interactomic Inhibition of ROR[alpha] Suppresses Th17-Related Inflammation</title><source>Taylor & Francis Open Access</source><source>DOVE Medical Press Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Ho, Chun-Chang ; Kim, Giha ; Mun, Chin Hee ; Kim, Ju-Won ; Han, Jieun ; Park, Ji Yoon ; Park, Yong-Beom ; Lee, Sang-Kyou</creator><creatorcontrib>Ho, Chun-Chang ; Kim, Giha ; Mun, Chin Hee ; Kim, Ju-Won ; Han, Jieun ; Park, Ji Yoon ; Park, Yong-Beom ; Lee, Sang-Kyou</creatorcontrib><description>Purpose: Th17 cells and their cytokines are implicated in the pathogenesis of various autoimmune diseases. Retinoic acid-related orphan receptor alpha (ROR[alpha]) is a transcription factor for the differentiation and the inflammatory functions of Th17 cells. In this study, we generated the nucleus-transducible form of transcription modulation domain of ROR[alpha] (nt-ROR[alpha]-TMD) to investigate the functional roles of ROR[alpha] in vitro and in vivo under normal physiological condition without genetic alteration. Methods: The functions of nt-ROR[alpha]-TMD were analyzed in vitro through flow cytometry, luciferase assay, ELISA, and transcriptome sequencing. Finally, the in vivo therapeutic effects of nt-ROR[alpha]-TMD were verified in dextran sulfate sodium (DSS)-induced colitis mice. Results: nt-ROR[alpha]-TMD was effectively delivered into the cell nucleus in a dose- and time-dependent manner without any cellular toxicity. nt-ROR[alpha]-TMD competitively inhibited the ROR[alpha]-mediated transcription but not ROR[gamma]t-mediated transcription. Secretion of IL-17A from the splenocytes was suppressed by nt-ROR[alpha]-TMD without affecting the secretion of Th1- or Th2-type cytokine and T cell activation events such as induction of CD69 and CD25. The differentiation potential of naive T cells into Th17 cells, not into Th1, Th2, or Treg cells, was significantly blocked by nt-ROR[alpha]-TMD. Consistently, mRNA sequencing analysis showed that nt-ROR[alpha]-TMD treatment down-regulated the expression of the genes related to the differentiation and functions of Th17 cells. Treatment of DSS-induced colitis mice with nt-ROR[alpha]-TMD improved the overall symptoms of colitis, such as body weight change, colon length, infiltration of inflammatory cells, and the level of inflammatory cytokines in the serum. In the mesenteric lymph node (MLN) of the nt-ROR[alpha]-TMD-treated mice, the population of CD4+IL-17A+ Th17 cells was reduced, and the population of CD4+Foxp3+ Treg cells increased. Conclusion: nt-ROR[alpha]-TMD has a potential to be developed as a novel therapeutic reagent for treating various inflammatory diseases in which Th17 cells are the leading pathological player. Keywords: retinoic acid-related orphan receptor, T helper 17, transcriptional modulation, DSS-induced colitis, inflammatory disease</description><identifier>ISSN: 1178-7031</identifier><identifier>EISSN: 1178-7031</identifier><identifier>DOI: 10.2147/JIR.S344031</identifier><language>eng</language><publisher>Dove Medical Press Limited</publisher><subject>Analysis ; Colitis ; Cytokines ; Development and progression ; Dextran ; Enzyme-linked immunosorbent assay ; Genetic aspects ; Genetic transcription ; Health aspects ; Inflammation ; Monoclonal antibodies ; Physiological aspects ; RNA sequencing ; Sulfates ; T cells ; Tretinoin</subject><ispartof>Journal of inflammation research, 2021-12, Vol.14, p.7091</ispartof><rights>COPYRIGHT 2021 Dove Medical Press Limited</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,862,27907,27908</link.rule.ids></links><search><creatorcontrib>Ho, Chun-Chang</creatorcontrib><creatorcontrib>Kim, Giha</creatorcontrib><creatorcontrib>Mun, Chin Hee</creatorcontrib><creatorcontrib>Kim, Ju-Won</creatorcontrib><creatorcontrib>Han, Jieun</creatorcontrib><creatorcontrib>Park, Ji Yoon</creatorcontrib><creatorcontrib>Park, Yong-Beom</creatorcontrib><creatorcontrib>Lee, Sang-Kyou</creatorcontrib><title>Transcriptional Interactomic Inhibition of ROR[alpha] Suppresses Th17-Related Inflammation</title><title>Journal of inflammation research</title><description>Purpose: Th17 cells and their cytokines are implicated in the pathogenesis of various autoimmune diseases. Retinoic acid-related orphan receptor alpha (ROR[alpha]) is a transcription factor for the differentiation and the inflammatory functions of Th17 cells. In this study, we generated the nucleus-transducible form of transcription modulation domain of ROR[alpha] (nt-ROR[alpha]-TMD) to investigate the functional roles of ROR[alpha] in vitro and in vivo under normal physiological condition without genetic alteration. Methods: The functions of nt-ROR[alpha]-TMD were analyzed in vitro through flow cytometry, luciferase assay, ELISA, and transcriptome sequencing. Finally, the in vivo therapeutic effects of nt-ROR[alpha]-TMD were verified in dextran sulfate sodium (DSS)-induced colitis mice. Results: nt-ROR[alpha]-TMD was effectively delivered into the cell nucleus in a dose- and time-dependent manner without any cellular toxicity. nt-ROR[alpha]-TMD competitively inhibited the ROR[alpha]-mediated transcription but not ROR[gamma]t-mediated transcription. Secretion of IL-17A from the splenocytes was suppressed by nt-ROR[alpha]-TMD without affecting the secretion of Th1- or Th2-type cytokine and T cell activation events such as induction of CD69 and CD25. The differentiation potential of naive T cells into Th17 cells, not into Th1, Th2, or Treg cells, was significantly blocked by nt-ROR[alpha]-TMD. Consistently, mRNA sequencing analysis showed that nt-ROR[alpha]-TMD treatment down-regulated the expression of the genes related to the differentiation and functions of Th17 cells. Treatment of DSS-induced colitis mice with nt-ROR[alpha]-TMD improved the overall symptoms of colitis, such as body weight change, colon length, infiltration of inflammatory cells, and the level of inflammatory cytokines in the serum. In the mesenteric lymph node (MLN) of the nt-ROR[alpha]-TMD-treated mice, the population of CD4+IL-17A+ Th17 cells was reduced, and the population of CD4+Foxp3+ Treg cells increased. Conclusion: nt-ROR[alpha]-TMD has a potential to be developed as a novel therapeutic reagent for treating various inflammatory diseases in which Th17 cells are the leading pathological player. Keywords: retinoic acid-related orphan receptor, T helper 17, transcriptional modulation, DSS-induced colitis, inflammatory disease</description><subject>Analysis</subject><subject>Colitis</subject><subject>Cytokines</subject><subject>Development and progression</subject><subject>Dextran</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Genetic aspects</subject><subject>Genetic transcription</subject><subject>Health aspects</subject><subject>Inflammation</subject><subject>Monoclonal antibodies</subject><subject>Physiological aspects</subject><subject>RNA sequencing</subject><subject>Sulfates</subject><subject>T cells</subject><subject>Tretinoin</subject><issn>1178-7031</issn><issn>1178-7031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptT01rwzAMNWODla6n_YHAYLd0Vuw69rGUbc0oFNKcNkZxHLvxcD6I0_8_h-3QwaSDnqT3hB5C94CXCdD06S3LlwdCKSZwhWYAKY_TgK8v8C1aeP-Fp0gxTegMvReDbL0abD_arpUuytpRD1KNXWNVaGpb2mkTdSbK9_mHdH0tP6PDue8H7b32UVFDGufayVFXQWCcbBo5Se7QjZHO68VvnaPi5bnYbOPd_jXbrHfxSXAeM7kihDCuQGhcYsFLrCpKFVNQCiGIkkASZkwJXCUrUBhYwrBhDEgqgJRkjh5-zp6k00fbmm4M_zfWq-OacUHFKrgPrOU_rJCVDka7Vhsb5n8EjxeCWks31r5z58mZvyR-Axmnb-U</recordid><startdate>20211231</startdate><enddate>20211231</enddate><creator>Ho, Chun-Chang</creator><creator>Kim, Giha</creator><creator>Mun, Chin Hee</creator><creator>Kim, Ju-Won</creator><creator>Han, Jieun</creator><creator>Park, Ji Yoon</creator><creator>Park, Yong-Beom</creator><creator>Lee, Sang-Kyou</creator><general>Dove Medical Press Limited</general><scope/></search><sort><creationdate>20211231</creationdate><title>Transcriptional Interactomic Inhibition of ROR[alpha] Suppresses Th17-Related Inflammation</title><author>Ho, Chun-Chang ; Kim, Giha ; Mun, Chin Hee ; Kim, Ju-Won ; Han, Jieun ; Park, Ji Yoon ; Park, Yong-Beom ; Lee, Sang-Kyou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g988-6a533368c19e0b098b0cd44c6c1b9993ca1326ffb18c251c016260f66137913b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Analysis</topic><topic>Colitis</topic><topic>Cytokines</topic><topic>Development and progression</topic><topic>Dextran</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Genetic aspects</topic><topic>Genetic transcription</topic><topic>Health aspects</topic><topic>Inflammation</topic><topic>Monoclonal antibodies</topic><topic>Physiological aspects</topic><topic>RNA sequencing</topic><topic>Sulfates</topic><topic>T cells</topic><topic>Tretinoin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ho, Chun-Chang</creatorcontrib><creatorcontrib>Kim, Giha</creatorcontrib><creatorcontrib>Mun, Chin Hee</creatorcontrib><creatorcontrib>Kim, Ju-Won</creatorcontrib><creatorcontrib>Han, Jieun</creatorcontrib><creatorcontrib>Park, Ji Yoon</creatorcontrib><creatorcontrib>Park, Yong-Beom</creatorcontrib><creatorcontrib>Lee, Sang-Kyou</creatorcontrib><jtitle>Journal of inflammation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ho, Chun-Chang</au><au>Kim, Giha</au><au>Mun, Chin Hee</au><au>Kim, Ju-Won</au><au>Han, Jieun</au><au>Park, Ji Yoon</au><au>Park, Yong-Beom</au><au>Lee, Sang-Kyou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcriptional Interactomic Inhibition of ROR[alpha] Suppresses Th17-Related Inflammation</atitle><jtitle>Journal of inflammation research</jtitle><date>2021-12-31</date><risdate>2021</risdate><volume>14</volume><spage>7091</spage><pages>7091-</pages><issn>1178-7031</issn><eissn>1178-7031</eissn><abstract>Purpose: Th17 cells and their cytokines are implicated in the pathogenesis of various autoimmune diseases. Retinoic acid-related orphan receptor alpha (ROR[alpha]) is a transcription factor for the differentiation and the inflammatory functions of Th17 cells. In this study, we generated the nucleus-transducible form of transcription modulation domain of ROR[alpha] (nt-ROR[alpha]-TMD) to investigate the functional roles of ROR[alpha] in vitro and in vivo under normal physiological condition without genetic alteration. Methods: The functions of nt-ROR[alpha]-TMD were analyzed in vitro through flow cytometry, luciferase assay, ELISA, and transcriptome sequencing. Finally, the in vivo therapeutic effects of nt-ROR[alpha]-TMD were verified in dextran sulfate sodium (DSS)-induced colitis mice. Results: nt-ROR[alpha]-TMD was effectively delivered into the cell nucleus in a dose- and time-dependent manner without any cellular toxicity. nt-ROR[alpha]-TMD competitively inhibited the ROR[alpha]-mediated transcription but not ROR[gamma]t-mediated transcription. Secretion of IL-17A from the splenocytes was suppressed by nt-ROR[alpha]-TMD without affecting the secretion of Th1- or Th2-type cytokine and T cell activation events such as induction of CD69 and CD25. The differentiation potential of naive T cells into Th17 cells, not into Th1, Th2, or Treg cells, was significantly blocked by nt-ROR[alpha]-TMD. Consistently, mRNA sequencing analysis showed that nt-ROR[alpha]-TMD treatment down-regulated the expression of the genes related to the differentiation and functions of Th17 cells. Treatment of DSS-induced colitis mice with nt-ROR[alpha]-TMD improved the overall symptoms of colitis, such as body weight change, colon length, infiltration of inflammatory cells, and the level of inflammatory cytokines in the serum. In the mesenteric lymph node (MLN) of the nt-ROR[alpha]-TMD-treated mice, the population of CD4+IL-17A+ Th17 cells was reduced, and the population of CD4+Foxp3+ Treg cells increased. Conclusion: nt-ROR[alpha]-TMD has a potential to be developed as a novel therapeutic reagent for treating various inflammatory diseases in which Th17 cells are the leading pathological player. Keywords: retinoic acid-related orphan receptor, T helper 17, transcriptional modulation, DSS-induced colitis, inflammatory disease</abstract><pub>Dove Medical Press Limited</pub><doi>10.2147/JIR.S344031</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1178-7031 |
| ispartof | Journal of inflammation research, 2021-12, Vol.14, p.7091 |
| issn | 1178-7031 1178-7031 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A689495178 |
| source | Taylor & Francis Open Access; DOVE Medical Press Journals; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central |
| subjects | Analysis Colitis Cytokines Development and progression Dextran Enzyme-linked immunosorbent assay Genetic aspects Genetic transcription Health aspects Inflammation Monoclonal antibodies Physiological aspects RNA sequencing Sulfates T cells Tretinoin |
| title | Transcriptional Interactomic Inhibition of ROR[alpha] Suppresses Th17-Related Inflammation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T14%3A12%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcriptional%20Interactomic%20Inhibition%20of%20ROR%5Balpha%5D%20Suppresses%20Th17-Related%20Inflammation&rft.jtitle=Journal%20of%20inflammation%20research&rft.au=Ho,%20Chun-Chang&rft.date=2021-12-31&rft.volume=14&rft.spage=7091&rft.pages=7091-&rft.issn=1178-7031&rft.eissn=1178-7031&rft_id=info:doi/10.2147/JIR.S344031&rft_dat=%3Cgale%3EA689495178%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A689495178&rfr_iscdi=true |